Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05292794 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Use of CereGate Therapy for Freezing of Gait in PD

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fieldsv14
  2. Primary completion date: Jun 2026 to Jun 2027
    • Study completion date: Jul 2026 to Jul 2027
    • Study description expanded, about 10 words
    • Site contacts updated at 1 of 7 sites
    v13
  3. Primary completion date: Jul 2025 to Jun 2026
    • Study completion date: Oct 2025 to Jul 2026
    • Study sites revised (7)
    v12
  4. Site contacts updated at 7 of 7 sitesv11
  5. Study sites revised (7)v10
Show 8 earlier versionsHide 8 earlier versions
  1. Primary completion date: Dec 2024 to Jul 2025v9 Show 5 more changesShow less
    • Study completion date: Feb 2025 to Oct 2025
    • Eligibility criteria expanded, about 15 words
    • Secondary endpoints: details revised at 1 of 1 entry
    • Study description revised
    • Site contacts updated at 3 of 7 sites
  2. Study sites: 6 to 7v8
  3. Primary completion date: Nov 2023 to Dec 2024
    • Study completion date: Dec 2023 to Feb 2025
    v7
  4. Study sites: 7 to 6v6
  5. Study sites: 5 to 7v5
  6. Re-verified, no change to tracked fieldsv4
  7. Phase: Phase 1 to Not applicablev3 Show 5 more changesShow less
    • Trial status: Not Yet Recruiting to Recruiting
    • Primary completion date: Apr 18, 2023 to Nov 2023
    • Study completion date: Apr 18, 2023 to Dec 2023
    • Site details revised at 5 of 5 sites
    • Study arms: 0 to 1
  8. Start date: Mar 15, 2022 to Apr 18, 2022v2 Show 4 more changesShow less
    • Primary and study completion dates: Mar 15, 2023 to Apr 18, 2023
    • Eligibility criteria expanded, about 7 words
    • Secondary endpoints: details revised at 1 of 1 entry
    • Study title shortened, about 11 words
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
A Multi-Center, Controlled Study to Evaluate Use of CereGate Therapy to Reduce Freezing of Gait in Participants Diagnosed with Parkinson's Disease.
Trial Details
NCT Number NCT05292794
Lead Sponsor CereGate Inc.
Conditions
(from sponsor)		 Parkinson Disease, Freezing of Gait, Deep Brain Stimulation
Related terms Gait Disorders, Neurologic, Mobility Limitation, Motor Disorders, Parkinson Disease
Enrollment 41 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov